197 related articles for article (PubMed ID: 38138199)
1. Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS.
Koo M; Lu MC
Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138199
[TBL] [Abstract][Full Text] [Related]
2. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
Jesus D; Matos A; Henriques C; Zen M; Larosa M; Iaccarino L; Da Silva JAP; Doria A; Inês LS
Ann Rheum Dis; 2019 Mar; 78(3):365-371. PubMed ID: 30626657
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.
Lai NS; Lu MC; Chang HH; Lo HC; Hsu CW; Huang KY; Tung CH; Hsu BB; Wu CH; Koo M
J Clin Med; 2021 May; 10(10):. PubMed ID: 34063379
[TBL] [Abstract][Full Text] [Related]
4. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
Abdelhady EI; Rabie M; Hassan RA
Clin Rheumatol; 2021 Nov; 40(11):4553-4558. PubMed ID: 34142298
[TBL] [Abstract][Full Text] [Related]
5. Increased frequency of hospital admissions with active systemic lupus erythematosus disease activity defined by two different disease activity indices: A cohort study.
Wang CL; Koo M; Hsu CW; Lu MC
Lupus; 2023 Jun; 32(7):864-872. PubMed ID: 37165549
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of hospital admissions in patients with active systemic lupus erythematosus (SLE) classified according to two different SLE disease activity indices: a prospective cohort study.
Lu MC; Hsu CW; Koo M; Lai NS
Clin Exp Rheumatol; 2023 Jul; 41(7):1409-1416. PubMed ID: 36377575
[TBL] [Abstract][Full Text] [Related]
7. Association of disease activity with depression and anxiety in systemic lupus erythematosus: A comparison of SLEDAI-2K and SLE-DAS.
Yang L; Gu B; Wang X; Ren Q; Shen M; Su D
Rheumatology (Oxford); 2024 Feb; ():. PubMed ID: 38305645
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes.
Onishi A; Tsuji H; Takase Y; Nakakubo Y; Iwasaki T; Kozuki T; Yoshida T; Shirakashi M; Onizawa H; Hiwa R; Kitagori K; Akizuki S; Nakashima R; Yoshifuji H; Tanaka M; Morinobu A
Rheumatology (Oxford); 2023 Dec; 62(12):3909-3915. PubMed ID: 36943365
[TBL] [Abstract][Full Text] [Related]
9. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus.
Leosuthamas P; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
Int J Rheum Dis; 2023 Apr; 26(4):667-672. PubMed ID: 36802112
[TBL] [Abstract][Full Text] [Related]
10. Predictors of flare in SLE patients fulfilling lupus low disease activity state: a cohort study of 292 patients with 36-month follow-up.
Cunha RN; Saraiva L; Jesus D; Doria A; da Silva JP; Inês LS
Rheumatology (Oxford); 2023 Nov; 62(11):3627-3635. PubMed ID: 36847423
[TBL] [Abstract][Full Text] [Related]
11. Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study.
Ma J; Zhang L; Yan M; Liu Z; Xue L
Lupus Sci Med; 2024 Jun; 11(1):. PubMed ID: 38862157
[TBL] [Abstract][Full Text] [Related]
12. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual.
Chitpet P; Chaiamnuay S; Narongroeknawin P; Asavatanabodee P; Leosuthamas P; Pakchotanon R
Int J Rheum Dis; 2023 Dec; 26(12):2509-2516. PubMed ID: 37875327
[TBL] [Abstract][Full Text] [Related]
13. The SLE-DAS provides an accurate and feasible flare tool in the clinical setting: a validation study.
Saraiva L; Cunha RN; Jesus D; Gatto M; Zen M; Iaccarino L; da Silva JAP; Doria A; Inês LS
Rheumatology (Oxford); 2024 Apr; 63(4):1123-1129. PubMed ID: 37458482
[TBL] [Abstract][Full Text] [Related]
14. Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity.
Jesus D; Larosa M; Henriques C; Matos A; Zen M; Tomé P; Alves V; Costa N; Le Guern V; Iaccarino L; Costedoat-Chalumeau N; Doria A; Inês LS
Ann Rheum Dis; 2021 Dec; 80(12):1568-1574. PubMed ID: 34407927
[TBL] [Abstract][Full Text] [Related]
15. Improving measures of disease activity in systemic lupus erythematosus.
Banjari M; Touma Z; Gladman DD
Expert Rev Clin Immunol; 2023 Feb; 19(2):193-202. PubMed ID: 36503376
[TBL] [Abstract][Full Text] [Related]
16. Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients.
Jesus D; Rodrigues M; Matos A; Henriques C; Pereira da Silva JA; Inês LS
Lupus; 2019 Apr; 28(5):607-612. PubMed ID: 30895904
[TBL] [Abstract][Full Text] [Related]
17. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
[TBL] [Abstract][Full Text] [Related]
18. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
19. What is the best instrument to measure disease activity in SLE? - SLE-DAS vs Easy BILAG.
Inês LS; Fredi M; Jesus D; Shumilova A; Franceschini F; Vital EM
Autoimmun Rev; 2024 Jan; 23(1):103428. PubMed ID: 37634675
[TBL] [Abstract][Full Text] [Related]
20. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
Ramirez GA; Canti V; Moiola L; Magnoni M; Rovere-Querini P; Coletto LA; Dagna L; Manfredi AA; Bozzolo EP
Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
